Inhalon Biopharma

Inhalon Biopharma Develops Inhalation Immunotherapies for the Treatment of Various Acute Respiratory Infections. The company’s platform aims to harness the power of biologics designed for mucosal application to treat and prevent respiratory infections, enabling physicians to target pathogens in mucus secretions to treat respiratory diseases.